Cross-sectional study shows 20.2% suicide attempt prevalence in drug-naïve major depressive disorder patients, suggesting links to anxiety and metabolic factors.
Suicide attempts are a critical concern among first-episode, drug-naïve (FEDN) patients with major depressive disorder (MDD). This cross-sectional study investigated the prevalence and correlates of suicide attempts in 1,701 working-age Chinese adults (18-59 years) with FEDN MDD. Sociodemographic data, clinical assessments, and biochemical data were obtained. Overall, 20.2% of participants reported lifetime suicide attempts. Multiple logistic regression identified four independent correlates: Hamilton Anxiety Scale (HAMA), clinical global impression of severity scale (CGI-s), systolic blood pressure, and thyroid peroxidase antibody levels. Additional analysis revealed significant pro-atherogenic lipid profile alterations in suicide attempters. Receiver operating characteristic curve analysis highlighted the high discriminative ability of HAMA and CGI-s for identifying suicide attempts. These findings underscore the importance of integrating psychological, cardiovascular, and metabolic markers in routine suicide risk evaluation for working-age FEDN MDD patients. Incorporating anxiety, blood pressure, lipid metabolism, and thyroid autoantibody assessment may enhance early detection and inform targeted interventions.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: